We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+22.23%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$18.5B
AUM Growth
+$2.83B
(+18%)
Cap. Flow
+$342M
Cap. Flow
% of AUM
1.85%
Top 10 Holdings %
Top 10 Hldgs %
16.55%
Holding
2,427
New
891
Increased
366
Reduced
546
Closed
599
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$163M |
| 2 |
Carnival Corporation Ltd
CCL
|
+$137M |
| 3 |
Repligen
RGEN
|
+$104M |
| 4 |
Biogen
BIIB
|
+$104M |
| 5 |
Zoetis
ZTS
|
+$91.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$173M |
| 2 |
Agilent Technologies
A
|
+$137M |
| 3 |
Fidelity National Information Services
FIS
|
+$86.2M |
| 4 |
Adobe
ADBE
|
+$76.2M |
| 5 |
Keurig Dr Pepper
KDP
|
+$75.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 28.24% |
| 2 | Consumer Discretionary | 12.89% |
| 3 | Financials | 10.77% |
| 4 | Technology | 9.62% |
| 5 | Industrials | 4.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1601
ASML
ASML
$636B
| $353K | ﹤0.01% |
+724
| New | +$305K |
|
1602
Tyler Technologies
TYL
$13B
| $353K | ﹤0.01% |
+809
| New | +$334K |
|
1603
Coca-Cola Consolidated
COKE
$12.4B
| $352K | ﹤0.01% |
13,230
-62,020
| -82% | -$1.58M |
|
1604
PACCAR
PCAR
$70.2B
| $352K | ﹤0.01% |
6,119
-74,773
| -92% | -$4.39M |
|
1605
Altimmune
ALT
$576M
| $350K | ﹤0.01% |
+31,049
| New | +$366K |
|
|
RIDE
1606
DELISTED
Lordstown Motors Corp. Class A Common Stock
RIDE
| $350K | ﹤0.01% |
+1,163
| New | +$366K |
|
1607
Baker Hughes
BKR
$60.1B
| $349K | ﹤0.01% |
+16,723
| New | +$294K |
|
1608
Liberty Broadband Class C
LBRDK
$4.44B
| $348K | ﹤0.01% |
2,198
-90,692
| -98% | -$13.8M |
|
1609
iShares MSCI India Small-Cap ETF
SMIN
$750M
| $343K | ﹤0.01% |
+8,100
| New | +$307K |
|
1610
Westlake Chemical Partners
WLKP
$770M
| $339K | ﹤0.01% |
+14,216
| New | +$288K |
|
|
TLMD
1611
DELISTED
SOC Telemed, Inc. Class A Common Stock
TLMD
| $339K | ﹤0.01% |
43,218
-606,782
| -93% | -$5.36M |
|
|
CUTR
1612
DELISTED
Cutera, Inc.
CUTR
| $338K | ﹤0.01% |
14,021
-30,258
| -68% | -$647K |
|
|
SPRB
1613
Spruce Biosciences
SPRB
$116M
| $337K | ﹤0.01% |
+185
| New | +$307K |
|
1614
UDR
UDR
$12.8B
| $336K | ﹤0.01% |
8,750
-303,759
| -97% | -$11.1M |
|
1615
Genesco
GCO
$416M
| $335K | ﹤0.01% |
11,124
+979
| +10% | +$25K |
|
|
DSKE
1616
DELISTED
Daseke, Inc. Common Stock
DSKE
| $334K | ﹤0.01% |
+57,486
| New | +$366K |
|
1617
Pricesmart
PSMT
$5.81B
| $330K | ﹤0.01% |
+3,622
| New | +$284K |
|
|
TNAV
1618
DELISTED
Telenav Inc.
TNAV
| $330K | ﹤0.01% |
+70,299
| New | +$317K |
|
1619
Bally's
BALY
$686M
| $329K | ﹤0.01% |
+6,546
| New | +$230K |
|
1620
Ichor Holdings
ICHR
$2.73B
| $329K | ﹤0.01% |
+10,924
| New | +$309K |
|
1621
WD-40
WDFC
$3.13B
| $329K | ﹤0.01% |
+1,240
| New | +$300K |
|
1622
iShares MSCI Turkey ETF
TUR
$203M
| $328K | ﹤0.01% |
12,373
-68,307
| -85% | -$1.49M |
|
|
AD
1623
Array Digital Infrastructure
AD
$2.99B
| $328K | ﹤0.01% |
+10,680
| New | +$325K |
|
|
HTLF
1624
DELISTED
Heartland Financial USA, Inc.
HTLF
| $322K | ﹤0.01% |
+7,979
| New | +$299K |
|
1625
Novavax
NVAX
$1.23B
| $321K | ﹤0.01% |
+2,877
| New | +$306K |
|
Similar funds
Marshall Wace's Q4 2020 Portfolio in Review
As of Q4 2020, Marshall Wace held 2,427 positions worth $18.5B, up 18% from $15.6B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Marshall Wace's Q4 2020 filing shows 891 new, 366 increased, 546 reduced and 599 closed positions. Its largest new stake was Natera: 911,254 shares worth $90.7M. The largest sale was Alphabet (Google) Class A, an estimated $173M.
By sector, the portfolio is most concentrated in Healthcare at 28% of assets, up from 24% a quarter earlier, followed by Consumer Discretionary and Financials.
- Marshall Wace's largest Q4 2020 buy was Natera: 911,254 shares worth $90.7M.
- Marshall Wace added most to Thermo Fisher Scientific in Q4 2020, an estimated $163M increase.
- Marshall Wace's biggest Q4 2020 reduction was Alphabet (Google) Class A, cutting an estimated $173M.
- Marshall Wace fully exited FedEx in Q4 2020, selling an estimated $69.6M.
- Marshall Wace's ten largest holdings make up 17% of its $18.5B portfolio in Q4 2020.
- Marshall Wace opened 891 new positions and closed 599 in Q4 2020.
- Marshall Wace's portfolio value rose 18% quarter-over-quarter to $18.5B.
Based on Marshall Wace's 13F filing for Q4 2020, filed 16 Feb 2021.